Key facts
- Atley Solutions’s last known valuation is $11.5M (May 2024).
- It has raised $10.7M; the latest was Later Stage VC ($5.7M) in Jun 2025.
- Notable investors include Almi Invest, Chalmers Ventures, Clean Sea Transport, Ekeblad Bostad, Erik Strömqvist — 12 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for Atley Solutions
- ·The full record, as it builds
Funding rounds
No funding rounds for Atley Solutions are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Atley Solutions
Developer of automated radiopharmaceutical manufacturing platforms intended for the dissemination of cancer cells. The company offers a platform that includes GMP-compliant production systems, scalable automation technology, integrated supply chain management, and quality control processes, enabling oncologists to treat patients more effectively and improve health and safety.
- Sector
- Healthcare
- HQ
- Gothenburg, Sweden
- Founded
- 2019
- Employees
- 12
- Website
- atley.com/
- Ownership
- Privately Held (backing)
Atley Solutions doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Atley Solutions shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Atley Solutions in its N-PORT filings yet. We sweep new filings monthly.